905 related articles for article (PubMed ID: 27106241)
1. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
2. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.
Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T
Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599
[TBL] [Abstract][Full Text] [Related]
3. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
[TBL] [Abstract][Full Text] [Related]
4. Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials.
von den Grün JM; Hartmann A; Fietkau R; Ghadimi M; Liersch T; Hohenberger W; Weitz J; Sauer R; Wittekind C; Ströbel P; Rödel C; Fokas E;
Radiother Oncol; 2018 Sep; 128(3):557-563. PubMed ID: 29929861
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
[TBL] [Abstract][Full Text] [Related]
6. Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response.
Shwaartz C; Haim N; Rosin D; Lawrence Y; Gutman M; Zmora O
Colorectal Dis; 2015 Jul; 17(7):595-9. PubMed ID: 25605475
[TBL] [Abstract][Full Text] [Related]
7. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
8. What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer?
Tranchart H; Lefèvre JH; Svrcek M; Flejou JF; Tiret E; Parc Y
Ann Surg Oncol; 2013 May; 20(5):1551-9. PubMed ID: 23188545
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
[TBL] [Abstract][Full Text] [Related]
10. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
11. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
[TBL] [Abstract][Full Text] [Related]
12. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
13. The effect of neoadjuvant therapy on the size, number, and distribution of mesorectal lymph nodes.
Yegen G; Keskin M; Büyük M; Kunduz E; Balık E; Sağlam EK; Kapran Y; Asoğlu O; Güllüoğlu M
Ann Diagn Pathol; 2016 Feb; 20():29-35. PubMed ID: 26706785
[TBL] [Abstract][Full Text] [Related]
14. Distal intramural and tumor spread in the mesorectum after neoadjuvant radiochemotherapy in rectal cancer: about 124 consecutive patients.
Guedj N; Maggiori L; Poté N; Norkowski E; Cros J; Bedossa P; Panis Y
Hum Pathol; 2016 Jun; 52():164-72. PubMed ID: 27210028
[TBL] [Abstract][Full Text] [Related]
15. Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT.
Perez RO; Habr-Gama A; Smith FM; Kosinski L; São Julião GP; Grzona E; Rawet V; Vianna MR; Proscurshim I; Lynn PB; Gama-Rodrigues J
J Surg Oncol; 2014 Jun; 109(8):853-8. PubMed ID: 24862927
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.
Bosch SL; Vermeer TA; West NP; Swellengrebel HA; Marijnen CA; Cats A; Verhoef C; van Lijnschoten I; de Wilt JH; Rutten HJ; Nagtegaal ID
Histopathology; 2016 Nov; 69(5):839-848. PubMed ID: 27270756
[TBL] [Abstract][Full Text] [Related]
17. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
[TBL] [Abstract][Full Text] [Related]
18. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
[TBL] [Abstract][Full Text] [Related]
19. Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.
Duldulao MP; Lee W; Streja L; Chu P; Li W; Chen Z; Kim J; Garcia-Aguilar J
Dis Colon Rectum; 2013 Feb; 56(2):142-9. PubMed ID: 23303141
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
